Biblio Discovery — Demo Discovery Service

7 hasil untuk "Athanasios Anagnostopoulos"

Menampilkan 1–7 · 2,51 detik · RSS

  1. Artikel Jurnal Teks lengkap

    An Overview of DRAM-Based Security Primitives

    Nikolaos Athanasios Anagnostopoulos; Stefan Katzenbeisser; John Chandy dkk.

    Cryptography, Vol. 2 No. 2 · 2018 · Inggris · DOAJ Scopus

    Recent developments have increased the demand for adequate security solutions, based on primitives that cannot be easily manipulated or altered, such as hardware-based primitives. Security primitives based on Dynamic Random Access Memory (DRAM) can provide cost-efficient and practical security…

  2. Artikel Jurnal Teks lengkap

    LP-MAB: Improving the Energy Efficiency of LoRaWAN Using a Reinforcement-Learning-Based Adaptive Configuration Algorithm

    Benyamin Teymuri; Reza Serati; Nikolaos Athanasios Anagnostopoulos dkk.

    Sensors, Vol. 23 No. 4 · 2023 · Inggris · DOAJ Scopus

    In the Internet of Things (IoT), Low-Power Wide-Area Networks (LPWANs) are designed to provide low energy consumption while maintaining a long communications’ range for End Devices (EDs). LoRa is a communication protocol that can cover a wide range with low energy consumption. To evaluate the…

  3. Artikel Jurnal

    Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents

    Efstathios Kastritis; Athanasios Anagnostopoulos; Maria Roussou dkk.

    Haematologica, Vol. 92 No. 4 · 2007 · Inggris · DOAJ Scopus

    The impact of high dose dexamethasone containing regimens with or without the novel agents thalidomide and bortezomib on the reversal of renal failure (RF) was evaluated in 41 consecutive newly diagnosed patients with multiple myeloma (MM) treated in a single institution. RF was reversed in 73% of…

  4. Artikel Jurnal

    Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma

    Meletios A. Dimopoulos; Vassilis L. Souliotis; Athanasios Anagnostopoulos dkk.

    Haematologica, Vol. 92 No. 11 · 2007 · Inggris · DOAJ Scopus

    Background and Objectives As new therapeutic options for multiple myeloma (MM) emerge, identification of biological markers which could predict clinical response to standard treatment with high-dose melphalan (HDM) supported by autologous stem cell transplantation (ASCT) becomes more…

  5. Artikel Jurnal Teks lengkap

    CNT-PUFs: Highly Robust and Heat-Tolerant Carbon-Nanotube-Based Physical Unclonable Functions

    Florian Frank; Simon Böttger; Nico Mexis dkk.

    Nanomaterials, Vol. 13 No. 22 · 2023 · Inggris · DOAJ Scopus

    In this work, we explored a highly robust and unique Physical Unclonable Function (PUF) based on the stochastic assembly of single-walled Carbon NanoTubes (CNTs) integrated within a wafer-level technology. Our work demonstrated that the proposed CNT-based PUFs are exceptionally robust with an…

  6. Artikel Jurnal Teks lengkap

    Intrinsic Run-Time Row Hammer PUFs: Leveraging the Row Hammer Effect for Run-Time Cryptography and Improved Security †

    Nikolaos Athanasios Anagnostopoulos; Tolga Arul; Yufan Fan dkk.

    Cryptography, Vol. 2 No. 3 · 2018 · Inggris · DOAJ Scopus

    Physical Unclonable Functions (PUFs) based on the retention times of the cells of a Dynamic Random Access Memory (DRAM) can be utilised for the implementation of cost-efficient and lightweight cryptographic protocols. However, as recent work has demonstrated, the times needed in order to generate…

  7. Artikel Jurnal

    Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

    Efstathios Kastritis; Athanasios Anagnostopoulos; Maria Roussou dkk.

    Haematologica, Vol. 92 No. 10 · 2007 · Inggris · DOAJ Scopus

    Background and Objectives High-dose melphalan and autologous stem cell transplantation is currently the treatment of choice for selected patients with AL amyloidosis; however, new treatments are needed for patients who are ineligible for or relapse after this procedure. Bortezomib is a proteasome…